Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 13/20 | 0.49 |
| ▸ | ESR1 | P03372 | 12/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | ESRRB | O95718 | 1/20 | 0.41 |
| ▸ | ESRRA | P11474 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL30464846 | 0.93 | ESR2 (0.44) | ESR2ESR1HTTCYP1A2CA1 | |
| SCHEMBL28805268 | 0.86 | ESR2 (0.51) | ESR2ESR1HTTCYP1A2CA1 | |
| SCHEMBL30345060 | 0.85 | ESR2 (0.57) | ESR2ESR1HTTCYP1A2CA1 | |
| SCHEMBL112028 | 0.85 | ESR2 (0.57) | ESR2ESR1HTTCYP1A2CA1 | |
| SCHEMBL5655546 | 0.81 | CYP1A2 (0.43) | ESR2ESR1CYP1A2CA2HSD17B1 | |
| SCHEMBL7038981 | 0.81 | CYP1A2 (0.43) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL30365640 | 0.81 | CYP1A2 (0.43) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL18322219 | 0.79 | HTT (0.53) | ESR2ESR1HTTCA1CA2 | |
| SCHEMBL8913792 | 0.78 | ESR2 (0.59) | ESR2ESR1CA1CA2 | |
| SCHEMBL31588569 | 0.78 | ESR2 (0.59) | ESR2ESR1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10729630-B2 | Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH | THE PROCTER & GAMBLE COMPANY (US) | 2020-08-04 | — | — | US | claimed |
| CN-105828786-B | Shaping keratin fibres using AN AN active agent comprising a functional group selected from-C (═ O) -, -C (═ O) -H and-C (═ O) -O-) | 宝洁公司 | 2020-07-07 | — | — | CN | claimed |
| EP-3082494-B1 | METHOD FOR SHAPING FIBROUS MATERIAL | PROCTER & GAMBLE (US) | 2018-12-05 | — | — | EP | claimed |
| EP-3082746-B1 | SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE | PROCTER & GAMBLE (US) | 2018-11-28 | — | — | EP | claimed |
| EP-3082736-B1 | SHAPING KERATIN FIBRES USING 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID AND/OR 1,2,3,4-BUTANETETRACARBOXYLIC ACID | PROCTER & GAMBLE (US) | 2018-08-08 | — | — | EP | claimed |
| EP-3082747-B1 | SHAPING KERATIN FIBRES USING A SUGAR | PROCTER & GAMBLE (US) | 2018-07-04 | — | — | EP | claimed |
| EP-3082731-B1 | SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH | PROCTER & GAMBLE (US) | 2018-07-04 | — | — | EP | claimed |
| EP-3082735-B1 | SHAPING KERATIN FIBRES USING OXOETHANOIC ACID AND/OR DERIVATIVES THEREOF | PROCTER & GAMBLE (US) | 2018-05-02 | — | — | EP | claimed |
| US-9918921-B2 | Methods for shaping fibrous material and treatment compositions therefor | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-20 | — | — | US | claimed |
| US-9877559-B2 | Methods for shaping fibrous material and treatment compositions therefor | THE PROCTER & GAMBLE COMANY (US) | 2018-01-30 | — | — | US | claimed |
| WO-2015094756-A1 | SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094789-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094757-A1 | SHAPING KERATIN FIBRES USING A SUGAR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015095685-A1 | SHAPING KERATIN FIBRES USING 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID AND/OR 1,2,3,4-BUTANETETRACARBOXYLIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094784-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094758-A1 | SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING A FUNCTIONAL GROUP SELECTED FROM THE GROUP CONSISTING OF: -C(=O)-, -C(=O)-H, AND -C(=O)-O- | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094787-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| US-20150174029-A1 | SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH | THE PROCTER & GAMBLE COMPANY | 2015-06-25 | — | — | US | claimed |
| WO-2015094790-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015095671-A1 | SHAPING KERATIN FIBRES USING OXOETHANOIC ACID AND/OR DERIVATIVES THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150174029-A1 | SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH | KRT18, CKAP4, JUP | ESR2 1798/4885ESR1 1956/4885HTT 3825/4885 |
| US-10729630-B2 | Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH | KRT18, CKAP4, JUP | ESR2 1568/4885ESR1 1922/4885HTT 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.